Clever Fermentation (Clever) today announced the completion of a strategic retooling of its leadership team, welcoming veteran biotech entrepreneur **Paul Neeb** to its Board of Directors. Neeb will play a pivotal role in shaping Clever's clinical trial and and regulatory strategy as the company accelerates its synthetic biology initiatives.

Clever is a leading biotech innovator focused on microbiome-balancing health ingredients, particularly those derived from fermented superfruits. Leveraging cutting-edge synthetic biology methods and microbial technologies, Clever aims to develop a new class of health ingredients that go far beyond what is currently imaginable.

"Paul Neeb is the ideal fit for Clever's board," said Sean Sears, CEO of Clever. "As a seasoned biotech executive, Paul brings extensive experience building teams in clinical trial design and execution, as well as in business development and transaction management. His appointment marks a major step forward in our journey to fully participate in the synthetic biology-driven product development space".

This board appointment follows a series of strategic moves earlier in the year, including partnerships with one of Europe's leading synbio-AI consultancies for project oversight and design, and with a pharma-grade contract research organization (CRO) to lead execution of its advanced science program.

"I fully align with Clever's vision," said Paul Neeb. "Before synthetic biology, biotic products lacked precision. Before AI, development cycles were too slow and costly. Today, we can develop highly targeted microbiome modulation products that address specific health outcomes with unprecedented accuracy".

Clever's expanded leadership and partnerships position the company at the forefront of next-generation biotic health innovation, driven by the convergence of AI, synthetic biology, and clinical science.

ABOUT CLEVER FERMENTATION:

Clever is a leading biotech innovator focused on microbiome-balancing health ingredients, particularly those derived from fermented superfruits. Leveraging cutting-edge synthetic biology methods and microbial technologies, Clever aims to develop a new class of health ingredients that go far beyond what is currently imaginable. Clever's products modulate the microbiome and target metabolic health opportunities, aiding the body's gut, brain, skin and cell health.

Media contact:
pr@cleverfruitproducts.com